Revatio is a prescription medication indicated for the treatment of pulmonary arterial hypertension. Its active ingredient is sildenafil which functions as a selective inhibitor of phosphodiesterase five. By blocking phosphodiesterase five the drug enhances the accumulation of cyclic guanosine monophosphate in vascular smooth muscle cells. This causes relaxation of pulmonary arterial smooth muscle and improves blood flow. The resulting decrease in pulmonary arterial pressure eases the workload of the right ventricle. Through these actions the medication lowers pulmonary arterial resistance and supports clinical status in patients with the disease.

Revatio is a phosphodiesterase type five inhibitor originally developed for pulmonary arterial hypertension. In pharmacology it is classified as a vasodilatory agent that enhances cyclic guanosine monophosphate signaling in smooth muscle cells. Its therapeutic role involves improving exercise capacity and hemodynamics in patients with functional limitations due to pulmonary vascular disease. The medication functions by inhibiting the enzymatic activity that normally terminates nitric oxide mediated smooth muscle relaxation. This inhibition leads to prolonged elevation of cyclic guanosine monophosphate, which promotes relaxation of pulmonary vascular smooth muscle. The resulting vasodilation reduces pulmonary arterial resistance and facilitates enhanced blood flow through the pulmonary circulation. Because the target mechanism is specific to type five phosphodiesterase, systemic side effects are generally limited to occasional headaches or flushing. Clinically, this biochemical interaction translates into measurable improvements in hemodynamic parameters and patient functional status.

Revatio may cause headache, flushing, and dizziness in some users. It can lead to gastrointestinal discomfort such as nausea or abdominal pain. Some individuals experience visual disturbances including blurred vision or color changes. Low blood pressure or a sensation of lightheadedness may occur, especially after standing quickly. Rarely, muscle aches or back pain have been reported. In isolated cases, priapism, a prolonged erection, has been observed but is extremely uncommon. These effects are generally mild but can vary in intensity depending on the individual.

Revatio can cause mild headache or dizziness in some individuals. Nasal congestion or a runny nose may occur as a mild symptom. Muscle pain or back ache are possible but typically infrequent. Visual disturbances such as blurred vision or color tint changes have been reported rarely. Low blood pressure may lead to lightheadedness especially after rapid changes in position. Some users experience nausea or gastrointestinal discomfort. These effects are generally transient and may lessen over time. Side effect profiles vary among patients and are not universal.